Home » Healthcare » Streptomyces Derivatives Market

Streptomyces Derivatives Market By Type Segment Analysis (Antibiotics, Enzymes, Antifungals, Immunomodulators, Others) By Region (Tuberculosis, Plague, Brucellosis, Endocarditis, Rabbit fever) by End-user Segment (Agriculture, Pharmaceuticals, Biotechnology, Food and Beverage, Others) By Drugs Segment (Seromycin, Capreomycin, Streptomycin, Spectinomycin, Tetracycline) By Regional Analysis 2023-2030

Summary
Table Of Content

Market Overview

The Streptomyces derivatives market demonstrates significant potential, with substantial growth projected in the coming years. Valued at USD 2,147.39 million in 2022, the market is expected to reach USD 3,458.73 million by 2030, exhibiting a strong compound annual growth rate (CAGR) of 7.05% from 2023 to 2030.

North America holds the leadership position in the market, driven by its favorable regulatory environment, advanced healthcare infrastructure, and increasing demand for innovative pharmaceutical products. Tuberculosis stands as the dominant indication for Streptomyces derivatives, fueled by the high prevalence of the disease and the urgent need for effective treatment options using Streptomyces-derived antibiotics.

Antibiotics claim the largest market share in the Streptomyces derivatives market due to their essential antimicrobial properties in combating various infectious diseases. The pharmaceutical industry emerges as the leading consumer, accounting for a significant 35% of the market share. This dominance can be attributed to the industry’s unwavering commitment to drug development and the growing demand for innovative therapeutics.

Given the favorable growth prospects and wide application range, the Streptomyces derivatives market is poised for consistent expansion in the years ahead.

Streptomyces Derivatives Market

Key market trends and drivers:

Increasing Demand for Antibiotics: The escalating global healthcare needs, coupled with the continued growth of the agriculture sector, have led to a surge in demand for antibiotics. Antibiotics derived from Streptomyces have become a pivotal resource in meeting this demand, thanks to their efficacy and wide-ranging applications.

Pharmaceutical Industry Growth: The pharmaceutical sector is witnessing significant expansion, particularly in developing countries. This expansion is driven by several factors, including population growth, increased access to healthcare, and a rise in disease prevalence. Consequently, the demand for Streptomyces derivatives in drug development has experienced a substantial rise.

Agricultural Applications: With the rise in popularity of sustainable farming practices worldwide, there has been an increased demand for Streptomyces-derived products in agriculture. These products play an integral role in crop protection, enhancing plant health, and improving soil quality. As the emphasis on environmentally friendly agricultural practices continues to intensify, the application of Streptomyces derivatives in agriculture is predicted to see further growth.

Biotechnology Advancements: The biotechnology field has seen considerable advancements, including the advent of genetic engineering techniques. These advancements have revolutionized the production of Streptomyces-derived compounds, making the process more efficient and cost-effective. Biotechnology advancements have enabled the engineering of Streptomyces strains with improved characteristics, leading to increased production yields and the discovery of new compounds with potential applications in pharmaceuticals and agriculture.

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

Key market challenges

Concerns Regarding Antibiotic Resistance: The escalating issue of antibiotic resistance on a global scale is a significant concern within the Streptomyces derivatives market. The misuse and overuse of antibiotics have resulted in the emergence of resistant strains of bacteria, thereby reducing the effectiveness of numerous antibiotics derived from Streptomyces. This increasing phenomenon of antibiotic resistance has prompted heightened scrutiny of antibiotic usage in healthcare and agricultural settings, potentially exerting a negative impact on the market.
Challenges in Regulatory Compliance: The regulatory landscape governing antibiotics and other pharmaceutical products is characterized by strictness and complexity. Stringent requirements exist for the approval of new products, often entailing exhaustive clinical trials and comprehensive data on safety and efficacy. These regulatory challenges can present substantial obstacles for market participants, potentially leading to delays in product launches, increased costs, and implications for overall market growth. While these regulations are essential for ensuring consumer safety, they can serve as limiting factors for the expansion of the Streptomyces derivatives market.

Streptomyces Derivatives Market

Regulatory Analysis

Regulatory Research and Development: By conducting extensive research on Streptomyces bacteria and their derivatives, scientists can delve deeper into understanding their unique properties and potential applications. This exploration may lead to the discovery of novel bioactive compounds with immense therapeutic and industrial value, revolutionizing various sectors.

Biotechnology Innovations: The ever-evolving field of biotechnology holds immense promise for the advancement of Streptomyces-derived products. Breakthroughs in synthetic biology and metabolic engineering enable scientists to optimize production processes, resulting in higher yields and improved product quality. These innovations paved the way for exciting possibilities in medicine, agriculture, and other industries.

Sustainable Agriculture: With the increasing global emphasis on sustainable agriculture and organic farming practices, there is a growing need for eco-friendly solutions to enhance crop protection and soil health. Streptomyces derivatives offer a potential avenue for achieving these goals, as they possess natural properties that can combat plant diseases and promote soil fertility. By harnessing the power of Streptomyces in sustainable agriculture, we can cultivate healthier crops while minimizing environmental impact.

Global Health Initiatives: In an era where infectious diseases continue to pose significant challenges, global health initiatives play a crucial role in combating these threats and improving healthcare access. As part of this effort, the demand for antibiotics and other pharmaceuticals remains high. Streptomyces-derived antibiotics have long been instrumental in treating various infections, and their importance in global health initiatives cannot be overstated. By supporting research and development in this field, we can drive innovation, discover new therapeutic agents, and ultimately improve the well-being of communities worldwide.

Bodies worldwide have set rigorous standards for the approval of antibiotics and other pharmaceutical products to ensure safety and efficacy. In the United States, for instance, the Food and Drug Administration (FDA) requires rigorous testing and clinical trials before approving. This involves preclinical testing on animals and three phases of clinical trials on humans. Only after a drug has demonstrated safety and effectiveness in the trial phases can it be approved for public use.

Similarly, in Europe, the European Medicines Agency (EMA) oversees the scientific evaluation, supervision, and safety monitoring of medicines. The process is comprehensive, involving the assessment of quality, safety, and efficacy data to ensure the drug’s benefits outweigh its risks.

In addition to these, the emergence of antibiotic resistance has led to global health organizations such as the World Health Organization (WHO) advocating for the judicious use of antibiotics. They encourage the development of new antibiotics but also stress their careful administration to combat resistance.

These stringent regulatory procedures, while necessary to ensure public safety and combat antibiotic resistance, can pose significant challenges for market players in the Streptomyces Derivatives Market, such as higher costs and longer timeframes for product approval. However, successful navigation and compliance with these regulatory landscapes are crucial for the successful commercialization of Streptomyces-derived products.

Streptomyces Derivatives Market

Competitive Analysis

The Streptomyces derivatives market is replete with key market players that are continuously contributing to its growth.

These leading players include:

Pfizer

Syngenta

MIT (Massachusetts Institute of Technology)

Nextbiotics

Merck & Co.

Novartis

GSK (GlaxoSmithKline)

Bayer AG

Eli Lilly

Sanofi

AstraZeneca

Roche

Others

Recent Developments and News:

Pfizer announced a $500 million investment in its gene therapy manufacturing facility to boost Streptomyces-derived product production.

Syngenta launched an innovative Streptomyces-derived biofungicide to combat fungal diseases in crops.

MIT scientists developed a novel technique to genetically engineer Streptomyces bacteria, facilitating the discovery of new antibiotics.

Several companies intensified R&D efforts to create new Streptomyces-derived antibiotics amidst concerns about antibiotic resistance.

Biotech startups like Nextbiotics are using advanced biotechnology to develop bacteriophage-based alternatives to traditional antibiotics.

These developments indicate a vibrant market with growth and innovation potential.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Segmentations Analysis

By Type Segment Analysis

Antibiotics,
Enzymes,
Antifungals,
Immunomodulators,
Others

By Indication Segment Analysis

Tuberculosis
Plague
Brucellosis
Endocarditis
Rabbit fever

By End-user Segment

Agriculture
Pharmaceuticals
Biotechnology,
Food and Beverage,
Others

By Drugs Segment

Seromycin
Capreomycin
Streptomycin
Spectinomycin
Tetracycline

By Regional Analysis

Table of Content

Chapter No. 1 :………. Introduction.. 23

1.1. Report Description. 23

1.1.1. Purpose of the Report 23

1.1.2. USP & Key Offerings. 23

1.2. Key Benefits for Stakeholders. 23

1.3. Target Audience. 24

1.4. Report Scope 24

Chapter No. 2 :………. Executive Summary. 28

2.1. Streptomyces Derivatives Market Snapshot. 28

2.2. Global Streptomyces Derivatives Market, 2017 – 2030 (USD Million) 30

2.1. Insights from Primary Respondents. 30

Chapter No. 3 :………. COVID 19 Impact Analysis. 31

3.1. Impact Assessment of COVID-19 Pandemic, By Region. 31

Chapter No. 4 :………. Streptomyces Derivatives Market – Industry Analysis. 32

4.1. Introduction 32

4.2. Market Drivers 33

4.2.1. Driving Factor 1 Analysis. 33

4.2.2. Driving Factor 2 Analysis. 34

4.3. Market Restraints. 34

4.3.1. Restraining Factor Analysis. 34

4.4. Market Opportunities. 35

4.4.1. Market Opportunity Analysis. 35

4.5. Porter’s Five Forces Analysis. 35

4.6. Value Chain Analysis. 36

Chapter No. 5 :………. Key Investment Pockets Analysis. 37

5.1. Top Investment Pockets. 37

5.1.1.1. Streptomyces Derivatives Market Attractiveness Analysis, By Type. 37

5.1.1.2. Streptomyces Derivatives Market Attractiveness Analysis, By Indication. 37

5.1.1.3. Streptomyces Derivatives Market Attractiveness Analysis, By End-user 38

5.1.1.4. Streptomyces Derivatives Market Attractiveness Analysis, By Drugs. 38

5.2. Product Life Cycle Analysis. 39

5.3. Incremental Revenue Growth Opportunity, 2023 – 2030. 40

5.3.1. Type 40

5.3.2. Indication. 40

5.3.3. End-user. 41

5.3.4. Drugs 41

Chapter No. 6 :………. Import Export Analysis. 42

6.1. Import Analysis by Region. 42

6.1.1. Global Streptomyces Derivatives Market Import Volume, By Region, 2017 – 2022 (USD Million) 42

6.2. Export Analysis by Region. 42

6.2.1. Global Streptomyces Derivatives Market Export Volume, By Region, 2017 – 2022 (USD Million) 42

Chapter No. 7 :………. Demand Supply Analysis. 43

7.1. Demand Analysis by Region. 43

7.1.1. Global Streptomyces Derivatives Market Demand Volume, By Region, 2017 – 2022 (USD Million) 43

7.2. Supply Analysis by Region. 43

7.2.1. Global Streptomyces Derivatives Market Supply Volume, By Region, 2017 – 2022 (USD Million) 43

Chapter No. 8 :………. Market Positioning of Key Players. 44

8.1. Company Market Share Analysis –2020 and 2022. 44

8.1.1. Global Streptomyces Derivatives Market: Company Market Share, 2022. 44

8.1.2. Global Streptomyces Derivatives Market: Company Market Share, 2022. 44

8.1. Global Streptomyces Derivatives Market Company Volume Market Share, 2022 45

8.2. Global Streptomyces Derivatives Market Company Revenue Market Share, 2022 46

8.3. Market Position of Key Players 2022. 47

8.3.1. Market Position of Key Players, 2022. 47

8.4. Strategic Developments. 48

8.4.1. Acquisitions & Mergers. 48

8.4.2. New Product Launch. 48

8.4.3. Regional Expansion. 48

Chapter No. 9 :………. Streptomyces Derivatives Market – By Type Segment Analysis. 49

9.1. Streptomyces Derivatives Market Overview, by Type Segment. 49

9.1.1. Global Streptomyces Derivatives Market Revenue Share, By Type, 2022 & 2030. 50

9.2. Antibiotics 51

9.2.1. Global Antibiotics Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 51

9.3. Enzymes 52

9.3.1. Global Antibiotics Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 52

9.4. Antifungals 53

9.4.1. Global Antifungals Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 53

9.5. Immunomodulators. 54

9.5.1. Global Immunomodulators Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 54

9.6. Others 55

9.6.1. Global Others Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 55

Chapter No. 10 :…….. Streptomyces Derivatives Market – By Indication Segment Analysis. 56

10.1. Streptomyces Derivatives Market Overview, by Indication Segment. 56

10.1.1. Global Streptomyces Derivatives Market Revenue Share, By Indication, 2022 & 2030. 57

10.2. Tuberculosis 58

10.2.1. Global Streptomyces Derivatives for Tuberculosis Market Revenue, By Region, 2017 – 2022 (USD Million) 58

10.3. Plague 59

10.3.1. Global Streptomyces Derivatives for Plague Market Revenue, By Region, 2017 – 2022 (USD Million) 59

10.4. Brucellosis 60

10.4.1. Global Streptomyces Derivatives for Brucellosis Market Revenue, By Region, 2017 – 2022 (USD Million) 60

10.5. Endocarditis 61

10.5.1. Global Streptomyces Derivatives for Endocarditis Market Revenue, By Region, 2017 – 2022 (USD Million) 61

10.6. Rabbit fever 62

10.6.1. Global Streptomyces Derivatives for Rabbit fever Market Revenue, By Region, 2017 – 2022 (USD Million) 62

Chapter No. 11 :…….. Streptomyces Derivatives Market – By End-user Segment Analysis. 63

11.1. Streptomyces Derivatives Market Overview, by End-user Segment. 63

11.1.1. Global Streptomyces Derivatives Market Revenue Share, By End-user, 2022 & 2030. 64

11.2. Agriculture 65

11.2.1. Global Agriculture Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 65

11.3. Pharmaceuticals. 66

11.3.1. Global Pharmaceuticals Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 66

11.4. Biotechnology 67

11.4.1. Global Biotechnology Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 67

11.5. Food and Beverage. 68

11.5.1. Global Food and Beverage Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 68

11.6. Others 69

11.6.1. Global Others Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 69

Chapter No. 12 :…….. Streptomyces Derivatives Market – By Drugs Segment Analysis. 70

12.1. Streptomyces Derivatives Market Overview, by Drugs Segment. 70

12.1.1. Global Streptomyces Derivatives Market Revenue Share, By Drugs, 2022 & 2030. 71

12.2. Seromycin 72

12.2.1. Global Seromycin Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 72

12.3. Capreomycin 73

12.3.1. Global Capreomycin Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 73

12.4. Streptomycin 74

12.4.1. Global Streptomycin Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 74

12.5. Spectinomycin 75

12.5.1. Global Spectinomycin Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 75

12.6. Tetracycline 76

12.6.1. Global Tetracycline Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 76

Chapter No. 13 :…….. Streptomyces Derivatives Market – Regional Analysis. 77

13.1. Streptomyces Derivatives Market Overview, by Region Segment. 77

13.1.1. Global Streptomyces Derivatives Market Revenue Share, By Region, 2022 & 2030. 78

13.1.2. Global Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 79

13.1.3. Global Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 80

13.1.4. Global Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 81

13.1.5. Global Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 82

13.1.6. Global Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 83

13.2. North America 84

13.2.1. North America Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 85

13.2.2. North America Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 86

13.2.3. North America Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 87

13.2.4. North America Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 88

13.2.5. North America Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 89

13.2.6. U.S. 90

13.2.7. Canada 90

13.2.8. Mexico 90

13.3. Europe 91

13.3.1. Europe Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 92

13.3.2. Europe Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 93

13.3.3. Europe Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 94

13.3.4. Europe Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 95

13.3.5. Europe Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 96

13.3.6. UK 97

13.3.7. France 97

13.3.8. Germany. 97

13.3.9. Italy 97

13.3.10. Spain. 97

13.3.11. Russia. 97

13.3.12. BENELUX. 97

13.3.13. Sweden. 97

13.3.14. Denmark. 97

13.3.15. Poland. 97

13.3.16. Austria. 97

13.3.17. Rest of Europe. 97

13.4. Asia Pacific 98

13.4.1. Asia Pacific Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 99

13.4.2. Asia Pacific Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 100

13.4.3. Asia Pacific Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 101

13.4.4. Asia Pacific Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 102

13.4.5. Asia Pacific Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 103

13.4.6. China 104

13.4.7. Japan 104

13.4.8. South Korea. 104

13.4.9. India 104

13.4.10. Thailand. 104

13.4.11. Indonesia. 104

13.4.12. Vietnam.. 104

13.4.13. Malaysia. 104

13.4.14. Philippines. 104

13.4.15. Taiwan. 104

13.4.16. Rest of Asia Pacific. 104

13.5. Latin America 105

13.5.1. Latin America Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 106

13.5.2. Latin America Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 107

13.5.3. Latin America Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 108

13.5.4. Latin America Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 109

13.5.5. Latin America Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 110

13.5.6. Brazil 111

13.5.7. Argentina. 111

13.5.8. Colombia. 111

13.5.9. Chile 111

13.5.10. Peru. 111

13.5.11. Rest of Latin America. 111

13.6. The Middle-East. 112

13.6.1. Middle East Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 113

13.6.2. Middle East Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 114

13.6.3. Middle East Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 115

13.6.4. Middle East Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 116

13.6.5. Middle East Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 117

13.6.6. GCC Countries. 118

13.6.7. Israel 118

13.6.8. Turkey 118

13.6.9. Iran 118

13.6.10. Rest of Middle East & Africa. 118

13.7. Africa 119

13.7.1. Africa Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 120

13.7.2. Africa Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 121

13.7.3. Africa Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 122

13.7.4. Africa Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 123

13.7.5. Africa Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 124

13.7.6. South Africa. 125

13.7.7. Egypt 125

13.7.8. Nigeria 125

13.7.9. Algeria 125

13.7.10. Morocco. 125

13.7.11. Rest of Africa. 125

Chapter No. 14 :…….. Company Profiles. 126

14.1. Eli Lilly and Company. 126

14.1.1. Company Overview.. 126

14.1.2. Product Portfolio. 126

14.1.3. Financial Overview.. 126

14.2. Pfizer Inc. 127

14.3. Novartis AG 127

14.4. Merck & Co., Inc. 127

14.5. AbbVie Inc. 127

14.6. Viatris Inc. 127

14.7. Zhejiang Hisun Pharmaceutical Co. Ltd. 127

14.8. Fera Pharmaceuticals, LLC. 127

14.9. Apotex Inc. 127

14.10. Akorn Operating Company LLC. 127

14.11. GSK 127

14.12. Sanofi 127

14.13. Bayer AG 127

14.14. Roche Holding AG.. 127

14.15. Johnson & Johnson. 127

14.16. AstraZeneca PL 127

Chapter No. 15 :…….. Research Methodology. 128

15.1. Research Methodology. 128

15.2. Phase I – Secondary Research. 129

15.3. Phase II – Data Modeling. 129

15.3.1. Company Share Analysis Model 130

15.3.2. Revenue Based Modeling. 130

15.4. Phase III – Primary Research. 131

15.5. Research Limitations. 132

15.5.1. Assumptions. 132

List of Figures

FIG NO. 1……….. Global Streptomyces Derivatives Market Volume & Revenue, 2017 – 2030 (USD Million) 30

FIG NO. 2……….. Porter’s Five Forces Analysis for Global Streptomyces Derivatives Market 35

FIG NO. 3……….. Value Chain Analysis for Global Streptomyces Derivatives Market 36

FIG NO. 4……….. Market Attractiveness Analysis, By Type. 37

FIG NO. 5……….. Market Attractiveness Analysis, By Indication. 37

FIG NO. 6……….. Market Attractiveness Analysis, By End-user 38

FIG NO. 7……….. Market Attractiveness Analysis, By Drugs. 38

FIG NO. 8……….. Product Life Cycle Analysis. 39

FIG NO. 9……….. Incremental Revenue Growth Opportunity by Type. 40

FIG NO. 10……… Incremental Revenue Growth Opportunity by Indication. 40

FIG NO. 11……… Incremental Revenue Growth Opportunity by End-user 41

FIG NO. 12……… Incremental Revenue Growth Opportunity by Drugs. 41

FIG NO. 13……… Company Share Analysis, 2020. 44

FIG NO. 14……… Company Share Analysis, 2022. 44

FIG NO. 15……… Streptomyces Derivatives Market – Company Volume Market Share, 2022. 45

FIG NO. 16……… Streptomyces Derivatives Market – Company Revenue Market Share, 2022. 46

FIG NO. 17……… Market Position of Key Players, 2022. 47

FIG NO. 18……… Global Streptomyces Derivatives Market Revenue Share, By Type, 2022 & 2030. 50

FIG NO. 19……… Global Streptomyces Derivatives Market for Antibiotics, Volume & Revenue (USD Million) 2017 – 2030. 51

FIG NO. 20……… Global Streptomyces Derivatives Market for Enzymes, Volume & Revenue (USD Million) 2017 – 2030. 52

FIG NO. 21……… Global Streptomyces Derivatives Market for Antifungals, Volume & Revenue (USD Million) 2017 – 2030. 53

FIG NO. 22……… Global Streptomyces Derivatives Market for Immunomodulators, Volume & Revenue (USD Million) 2017 – 2030. 54

FIG NO. 23……… Global Streptomyces Derivatives Market for Others, Volume & Revenue (USD Million) 2017 – 2030. 55

FIG NO. 24……… Global Streptomyces Derivatives Market Revenue Share, By Indication, 2022 & 2030. 57

FIG NO. 25……… Global Streptomyces Derivatives Market for Tuberculosis, Volume & Revenue (USD Million) 2017 – 2030. 58

FIG NO. 26……… Global Streptomyces Derivatives Market for Plague, Volume & Revenue (USD Million) 2017 – 2030. 59

FIG NO. 27……… Global Streptomyces Derivatives Market for Brucellosis, Volume & Revenue (USD Million) 2017 – 2030. 60

FIG NO. 28……… Global Streptomyces Derivatives Market for Endocarditis, Volume & Revenue (USD Million) 2017 – 2030. 61

FIG NO. 29……… Global Streptomyces Derivatives Market for Rabbit fever, Volume & Revenue (USD Million) 2017 – 2030. 62

FIG NO. 30……… Global Streptomyces Derivatives Market Revenue Share, By End-user, 2022 & 2030. 64

FIG NO. 31……… Global Streptomyces Derivatives Market for Agriculture, Volume & Revenue (USD Million) 2017 – 2030. 65

FIG NO. 32……… Global Streptomyces Derivatives Market for Pharmaceuticals, Volume & Revenue (USD Million) 2017 – 2030. 66

FIG NO. 33……… Global Streptomyces Derivatives Market for Biotechnology, Volume & Revenue (USD Million) 2017 – 2030. 67

FIG NO. 34……… Global Streptomyces Derivatives Market for Food and Beverage, Volume & Revenue (USD Million) 2017 – 2030. 68

FIG NO. 35……… Global Streptomyces Derivatives Market for Others, Volume & Revenue (USD Million) 2017 – 2030. 69

FIG NO. 36……… Global Streptomyces Derivatives Market Revenue Share, By Drugs, 2022 & 2030. 71

FIG NO. 37……… Global Streptomyces Derivatives Market for Seromycin, Volume & Revenue (USD Million) 2017 – 2030. 72

FIG NO. 38……… Global Streptomyces Derivatives Market for Capreomycin, Volume & Revenue (USD Million) 2017 – 2030. 73

FIG NO. 39……… Global Streptomyces Derivatives Market for Streptomycin, Volume & Revenue (USD Million) 2017 – 2030. 74

FIG NO. 40……… Global Streptomyces Derivatives Market for Spectinomycin, Volume & Revenue (USD Million) 2017 – 2030. 75

FIG NO. 41……… Global Streptomyces Derivatives Market for Tetracycline, Volume & Revenue (USD Million) 2017 – 2030. 76

FIG NO. 42……… Global Streptomyces Derivatives Market Revenue Share, By Region, 2022 & 2030. 78

FIG NO. 43……… North America Streptomyces Derivatives Market Volume & Revenue, 2017 – 2022 (USD Million) 84

FIG NO. 44……… Europe Streptomyces Derivatives Market Volume & Revenue, 2017 – 2022 (USD Million) 91

FIG NO. 45……… Asia Pacific Streptomyces Derivatives Market Volume & Revenue, 2017 – 2022 (USD Million) 98

FIG NO. 46……… Latin America Streptomyces Derivatives Market Volume & Revenue, 2017 – 2022 (USD Million) 105

FIG NO. 47……… The Middle-East Streptomyces Derivatives Market Volume & Revenue, 2017 – 2022 (USD Million) 112

FIG NO. 48……… Africa Streptomyces Derivatives Market Volume & Revenue, 2017 – 2022 (USD Million) 119

FIG NO. 49……… Research Methodology – Detailed View.. 128

FIG NO. 50……… Research Methodology. 129

List of Tables

TABLE NO. 1. :…. Global Streptomyces Derivatives Market: Snapshot 25

TABLE NO. 2. :…. Drivers for the Streptomyces Derivatives Market: Impact Analysis. 30

TABLE NO. 3. :…. Restraints for the Streptomyces Derivatives Market: Impact Analysis. 31

TABLE NO. 4. :…. Global Streptomyces Derivatives Market Import Volume, By End-user, 2017 – 2022 (USD Million) 39

TABLE NO. 5. :…. Global Streptomyces Derivatives Market Export Volume, By End-user, 2017 – 2022 (USD Million) 39

TABLE NO. 6. :…. Global Streptomyces Derivatives Market Demand Volume, By End-user, 2017 – 2022 (USD Million) 40

TABLE NO. 7. :…. Global Streptomyces Derivatives Market Supply Volume, By End-user, 2017 – 2022 (USD Million) 40

TABLE NO. 8. :…. Global Antibiotics Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 48

TABLE NO. 9. :…. Global Antibiotics Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 48

TABLE NO. 10. :.. Global Antibiotics Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 49

TABLE NO. 11. :.. Global Antibiotics Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 49

TABLE NO. 12. :.. Global Antifungals Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 50

TABLE NO. 13. :.. Global Antifungals Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 50

TABLE NO. 14. :.. Global Immunomodulators Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 51

TABLE NO. 15. :.. Global Immunomodulators Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 51

TABLE NO. 16. :.. Global Others Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 52

TABLE NO. 17. :.. Global Others Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 52

TABLE NO. 18. :.. Global Streptomyces Derivatives for Tuberculosis Market Revenue, By Region, 2017 – 2022 (USD Million) 55

TABLE NO. 19. :.. Global Streptomyces Derivatives for Tuberculosis Market Revenue, By Region, 2023– 2030 (USD Million) 55

TABLE NO. 20. :.. Global Streptomyces Derivatives for Plague Market Revenue, By Region, 2017 – 2022 (USD Million) 56

TABLE NO. 21. :.. Global Streptomyces Derivatives for Plague Market Revenue, By Region, 2023– 2030 (USD Million) 56

TABLE NO. 22. :.. Global Streptomyces Derivatives for Brucellosis Market Revenue, By Region, 2017 – 2022 (USD Million) 57

TABLE NO. 23. :.. Global Streptomyces Derivatives for Brucellosis Market Revenue, By Region, 2023– 2030 (USD Million) 57

TABLE NO. 24. :.. Global Streptomyces Derivatives for Endocarditis Market Revenue, By Region, 2017 – 2022 (USD Million) 58

TABLE NO. 25. :.. Global Streptomyces Derivatives for Endocarditis Market Revenue, By Region, 2023– 2030 (USD Million) 58

TABLE NO. 26. :.. Global Streptomyces Derivatives for Rabbit fever Market Revenue, By Region, 2017 – 2022 (USD Million) 59

TABLE NO. 27. :.. Global Streptomyces Derivatives for Rabbit fever Market Revenue, By Region, 2023– 2030 (USD Million) 59

TABLE NO. 28. :.. Global Agriculture Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 62

TABLE NO. 29. :.. Global Agriculture Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 62

TABLE NO. 30. :.. Global Pharmaceuticals Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 63

TABLE NO. 31. :.. Global Pharmaceuticals Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 63

TABLE NO. 32. :.. Global Biotechnology Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 64

TABLE NO. 33. :.. Global Biotechnology Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 64

TABLE NO. 34. :.. Global Food and Beverage Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 65

TABLE NO. 35. :.. Global Food and Beverage Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 65

TABLE NO. 36. :.. Global Others Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 66

TABLE NO. 37. :.. Global Others Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 66

TABLE NO. 38. :.. Global Seromycin Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 69

TABLE NO. 39. :.. Global Seromycin Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 69

TABLE NO. 40. :.. Global Capreomycin Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 70

TABLE NO. 41. :.. Global Capreomycin Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 70

TABLE NO. 42. :.. Global Streptomycin Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 71

TABLE NO. 43. :.. Global Streptomycin Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 71

TABLE NO. 44. :.. Global Spectinomycin Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 72

TABLE NO. 45. :.. Global Spectinomycin Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 72

TABLE NO. 46. :.. Global Tetracycline Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 73

TABLE NO. 47. :.. Global Tetracycline Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 73

TABLE NO. 48. :.. Global Streptomyces Derivatives Market Revenue, By Region, 2017 – 2022 (USD Million) 76

TABLE NO. 49. :.. Global Streptomyces Derivatives Market Revenue, By Region, 2023– 2030 (USD Million) 76

TABLE NO. 50. :.. Global Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 77

TABLE NO. 51. :.. Global Streptomyces Derivatives Market Revenue, By Type, 2023– 2030 (USD Million) 77

TABLE NO. 52. :.. Global Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 78

TABLE NO. 53. :.. Global Streptomyces Derivatives Market Revenue, By Indication, 2023– 2030 (USD Million) 78

TABLE NO. 54. :.. Global Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 79

TABLE NO. 55. :.. Global Streptomyces Derivatives Market Revenue, By End-user, 2023– 2030 (USD Million) 79

TABLE NO. 56. :.. Global Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 80

TABLE NO. 57. :.. Global Streptomyces Derivatives Market Revenue, By Drugs, 2023– 2030 (USD Million) 80

TABLE NO. 58. :.. North America Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 82

TABLE NO. 59. :.. North America Streptomyces Derivatives Market Revenue, By Country, 2023– 2030 (USD Million) 82

TABLE NO. 60. :.. North America Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 83

TABLE NO. 61. :.. North America Streptomyces Derivatives Market Revenue, By Type, 2023– 2030 (USD Million) 83

TABLE NO. 62. :.. North America Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 84

TABLE NO. 63. :.. North America Streptomyces Derivatives Market Revenue, By Indication, 2023– 2030 (USD Million) 84

TABLE NO. 64. :.. North America Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 85

TABLE NO. 65. :.. North America Streptomyces Derivatives Market Revenue, By End-user, 2023– 2030 (USD Million) 85

TABLE NO. 66. :.. North America Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 86

TABLE NO. 67. :.. North America Streptomyces Derivatives Market Revenue, By Drugs, 2023– 2030 (USD Million) 86

TABLE NO. 68. :.. Europe Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 89

TABLE NO. 69. :.. Europe Streptomyces Derivatives Market Revenue, By Country, 2023– 2030 (USD Million) 89

TABLE NO. 70. :.. Europe Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 90

TABLE NO. 71. :.. Europe Streptomyces Derivatives Market Revenue, By Type, 2023– 2030 (USD Million) 90

TABLE NO. 72. :.. Europe Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 91

TABLE NO. 73. :.. Europe Streptomyces Derivatives Market Revenue, By Indication, 2023– 2030 (USD Million) 91

TABLE NO. 74. :.. Europe Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 92

TABLE NO. 75. :.. Europe Streptomyces Derivatives Market Revenue, By End-user, 2023– 2030 (USD Million) 92

TABLE NO. 76. :.. Europe Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 93

TABLE NO. 77. :.. Europe Streptomyces Derivatives Market Revenue, By Drugs, 2023– 2030 (USD Million) 93

TABLE NO. 78. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 96

TABLE NO. 79. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By Country, 2023– 2030 (USD Million) 96

TABLE NO. 80. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 97

TABLE NO. 81. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By Type, 2023– 2030 (USD Million) 97

TABLE NO. 82. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 98

TABLE NO. 83. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By Indication, 2023– 2030 (USD Million) 98

TABLE NO. 84. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 99

TABLE NO. 85. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By End-user, 2023– 2030 (USD Million) 99

TABLE NO. 86. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 100

TABLE NO. 87. :.. Asia Pacific Streptomyces Derivatives Market Revenue, By Drugs, 2023– 2030 (USD Million) 100

TABLE NO. 88. :.. Latin America Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 103

TABLE NO. 89. :.. Latin America Streptomyces Derivatives Market Revenue, By Country, 2023– 2030 (USD Million) 103

TABLE NO. 90. :.. Latin America Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 104

TABLE NO. 91. :.. Latin America Streptomyces Derivatives Market Revenue, By Type, 2023– 2030 (USD Million) 104

TABLE NO. 92. :.. Latin America Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 105

TABLE NO. 93. :.. Latin America Streptomyces Derivatives Market Revenue, By Indication, 2023– 2030 (USD Million) 105

TABLE NO. 94. :.. Latin America Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 106

TABLE NO. 95. :.. Latin America Streptomyces Derivatives Market Revenue, By End-user, 2023– 2030 (USD Million) 106

TABLE NO. 96. :.. Latin America Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 107

TABLE NO. 97. :.. Latin America Streptomyces Derivatives Market Revenue, By Drugs, 2023– 2030 (USD Million) 107

TABLE NO. 98. :.. Middle East Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 110

TABLE NO. 99. :.. Middle East Streptomyces Derivatives Market Revenue, By Country, 2023– 2030 (USD Million) 110

TABLE NO. 100. :. Middle East Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 111

TABLE NO. 101. :. Middle East Streptomyces Derivatives Market Revenue, By Type, 2023– 2030 (USD Million) 111

TABLE NO. 102. :. Middle East Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 112

TABLE NO. 103. :. Middle East Streptomyces Derivatives Market Revenue, By Indication, 2023– 2030 (USD Million) 112

TABLE NO. 104. :. Middle East Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 113

TABLE NO. 105. :. Middle East Streptomyces Derivatives Market Revenue, By End-user, 2023– 2030 (USD Million) 113

TABLE NO. 106. :. Middle East Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 114

TABLE NO. 107. :. Middle East Streptomyces Derivatives Market Revenue, By Drugs, 2023– 2030 (USD Million) 114

TABLE NO. 108. :. Africa Streptomyces Derivatives Market Revenue, By Country, 2017 – 2022 (USD Million) 117

TABLE NO. 109. :. Africa Streptomyces Derivatives Market Revenue, By Country, 2023– 2030 (USD Million) 117

TABLE NO. 110. :. Africa Streptomyces Derivatives Market Revenue, By Type, 2017 – 2022 (USD Million) 118

TABLE NO. 111. :. Africa Streptomyces Derivatives Market Revenue, By Type, 2023– 2030 (USD Million) 118

TABLE NO. 112. :. Africa Streptomyces Derivatives Market Revenue, By Indication, 2017 – 2022 (USD Million) 119

TABLE NO. 113. :. Africa Streptomyces Derivatives Market Revenue, By Indication, 2023– 2030 (USD Million) 119

TABLE NO. 114. :. Africa Streptomyces Derivatives Market Revenue, By End-user, 2017 – 2022 (USD Million) 120

TABLE NO. 115. :. Africa Streptomyces Derivatives Market Revenue, By End-user, 2023– 2030 (USD Million) 120

TABLE NO. 116. :. Africa Streptomyces Derivatives Market Revenue, By Drugs, 2017 – 2022 (USD Million) 121

TABLE NO. 117. :. Africa Streptomyces Derivatives Market Revenue, By Drugs, 2023– 2030 (USD Million) 121

What was Pfizer’s key development in the Streptomyces derivatives market?

Pfizer, a major player in the Streptomyces Derivatives Market, notably acquired Array BioPharma in July 2019. This merger brought advanced genetics and biotechnology capabilities to Pfizer, potentially enabling innovative applications of Streptomyces derivatives. Array BioPharma’s expertise in cancer research also provides new avenues for therapeutic applications of Streptomyces-derived antibiotics.

Which new product did Syngenta launch in the Streptomyces derivatives market?

Syngenta launched an innovative Streptomyces-derived biofungicide to combat fungal diseases in crops. This development showcases the company’s commitment to leveraging Streptomyces derivatives for sustainable agriculture.

What innovative technique has been developed by MIT scientists related to Streptomyces bacteria?

Scientists from MIT developed a novel technique to genetically engineer Streptomyces bacteria. This advancement is especially significant as it facilitates the discovery of new antibiotics, thereby playing a crucial role in the battle against antibiotic resistance.

Purchase Options

Single User

$3699

Multi User

$4699

Custom Report

$6699

Request Free Sample

Have a question?

Don’t settle for less – trust Mitul to help you find the best solution.

Call: +91 6232 49 3207

EMAIL MITUL

Report delivery within 24 to 48 hours

– Other Info –

–What people say?-

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –